Certified by Founder Lodge
Syremis Therapeutics
- ND
START UP
1 Disclosed Funding Rounds $165,000,000
0 Participating Investments
-
Founded date
2025
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Syremis Therapeutics is a clinical-stage biopharmaceutical company developing novel medicines to make a profound impact on the treatment of mental health. The company’s neuropsychiatric pipel
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| December, 19 ,2025 | Series A | $165,000,000 |
Bain Capital
Third Rock Ventures
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Katalist | $1,500,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
